4-Substituted anilides as selective melatonin MT2 receptor agonists.

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Neuroscience

Background:

• Melatonergic receptors, MT(1) and MT(2), are crucial for regulating circadian rhythms and sleep.
• Developing selective ligands for these receptors is important for therapeutic interventions.
• Previous research has explored various chemical scaffolds for melatonergic activity.

Purpose of the Study:

• To synthesize and characterize novel 4-substituted anilides.
• To evaluate their binding affinity and selectivity for human MT(1) and MT(2) receptors.
• To identify potential therapeutic agents targeting the melatonergic system.

Main Methods:

• Synthesis of a series of 4-substituted anilides.
• In vitro radioligand binding assays to determine receptor affinity.
• Selectivity assays comparing MT(1) and MT(2) receptor binding.
• Functional assays to assess receptor agonism/antagonism.

Main Results:

• Several synthesized butyramides exhibited subnanomolar binding affinity for the MT(2) receptor.
• Compounds 26, 39, 42, 52, 57, and 58 demonstrated high MT(2) selectivity (>70-fold over MT(1)).
• Compound 26 was identified as a full agonist at the MT(2) receptor.

Conclusions:

• The reported 4-substituted anilides represent a promising class of compounds for targeting the MT(2) receptor.
• Compound 26, with its full agonism and high selectivity, warrants further investigation for potential therapeutic applications.
• These findings contribute to the development of novel melatonergic agents for sleep and circadian rhythm disorders.